pcn poster

Posters

A Comparison of Barriers and Drivers Between Prescribing and Non-Prescribing Psychiatric Care Providers Regarding Use of Digital Medication Adherence Platforms

Background: Tracking medication adherence through an ingestible event monitoring (IEM) sensor could benefit seriously mentally ill patients (SMI). Psychiatric providers may be reluctant t...

Jennifer Clerie , BS ;

Charles Ruetsch , PhD;

Heidi Waters , PhD, MBA;

Tigwa Davis , PhD;

Dawn Velligan , PhD;

Delbert Robinson , MD;

Chris Jaeger , MD, MBA;

William Carpenter , MD;

Joshua Liberman , PhD;

Felicia Forma , BSc;

11/22/2019

Characteristics and Healthcare Burden of Patients With Schizophrenia Treated in a United States Integrated Healthcare System

Objective: Limited data are available on patient characteristics and healthcare burden of schizophrenia in a healthcare system. This analysis examined the characteristics and healthcare b...

Kruti Joshi , MPH, MD;

Felix Sanchez , MS;

Charmi Patel , BS , RN, BSN, MPH;

Rohan Mahabaleshwarkar , PhD;

Jesse Fishman , PharmD;

Timothy Hetherington , MS;

Constance Krull , MSPH;

Dee Lin , PharmD, MS;

Oleg Tcheremissine , MD;

11/22/2019

Lurasidone and Metabolic Syndrome: Results From Short- and Long-Term Clinical Studies in Patients With Bipolar Depression

Background: The elevated prevalence of metabolic syndrome (MetS) in patients with depression has been associated with increased mortality rates. The aim of this post-hoc analysis was to a...

Andrei Pikalov , MD, PhD;

Michael Tocco , PhD;

Yongcai Mao , PhD;

John Newcomer , MD;

11/22/2019

Psychedelics and Wellness Study (PAWS): Psychedelic Use and Its Impact on Long-term Wellness and Holistic Mental Health & Behavioral Markers – Results From an Online Anonymous Nationwide Survey of Adults

OBJECTIVE: This survey intends to fill a research and educational gap by conducting an in-depth anonymous online survey of U.S. adults, investigating the impact of past psychedelic use an...

Rakesh Jain , MD, MPH, RD;

Nick Moore , MBA;

Saundra Jain , MA, PsyD, LPC;

11/22/2019

Impact of Antipsychotic Treatment Switching in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder

BACKGROUND: Antipsychotics are commonly used for maintenance treatment of schizophrenia (SZ), bipolar disorder (BP), and major depressive disorder (MDD). Treatment adherence reduces the r...

Benjamin Carroll , PharmD;

Fan Mu , PhD;

Darren Thomason , MBA;

Michael Philbin , MSc, PharmD, MBA;

Rajeev Ayyagari , PhD;

11/22/2019

Efficacy and Safety of SEP-363856, a Novel Psychotropic Agent with a Non-D2 Mechanism of Action, in the Treatment of Schizophrenia: A 4-Week, Randomized, Placebo-Controlled Trial

Background: SEP-363856 is a novel trace amine associated receptor-1 (TAAR1)/5-HT1A agonist with no dopamine-D2/5-HT2A antagonist activity which has shown efficacy in animal models of psyc...

Antony Loebel , MD;

Justine Kent , MD;

Robert Goldman , PhD;

Hailong Cheng , PhD;

Seth Hopkins , PhD;

Kenneth Koblan , PhD;

11/22/2019

Medication Optimization Using Pharmacogenomic Testing and a Drug Interaction Guide in a Complex Mental Health Population

Background: Psychiatric polypharmacy may be an indication of complex mental health needs that require careful consideration in medication treatment planning to avoid drug-drug interaction...

Zohra Lodin , MD;

Amanda Wood , PhD;

Luz Stark , MD;

Deepika Agrawal , MD;

Terri Dupper-Knoper , ARNP;

Rosa Merino , MD;

Alison Deem , MD;

Sonia Lim , MD;

11/22/2019

Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results From the Clinical Development Program

Aim: To evaluate the cardiac safety of esketamine nasal spray administered to patients with treatment-resistant depression (TRD). Methods: Cardiovascular (CV) effects of esketamine nasal...

Jaskaran Singh , MD;

Teodora Doherty , MD;

Michael Weber , MD, PhD;

Ewa Wajs , MD, PhD;

Rama Melkote , MSc, MPH;

Janice Miller , MD;

11/22/2019

Hospitalization Risk in Pediatric Bipolar Patients Treated with Lurasidone vs. Other Oral Atypical Antipsychotics: A Real-World Retrospective Claims Database Study

Background: Real-world evidence on atypical antipsychotic (AAP) use in pediatric bipolar disorder is limited. Objective: To compare the risk of all-cause and psychiatric hospitalization ...

Li Wang , MS, MBA, PhD, MA;

Daisy Ng-Mak , PhD;

Sulena Shrestha , MPH;

Aditi Kadakia , MS;

Antony Loebel , MD;

11/22/2019

Medication Madness: Aripiprazole-Induced Psychosis

Aripiprazole is an atypical antipsychotic that is FDA approved to treat a variety of psychiatric illnesses, including schizophrenia, bipolar I disorder, autism spectrum disorder, Tourette...

Praveen Narahari , MD;

Jazmin Jazmin ;

Taylor Ousley ;

11/22/2019

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Posters

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products